Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.270
+0.020 (0.62%)
May 26, 2026, 10:48 AM EDT - Market open
Rezolute Market Cap
Rezolute has a market cap or net worth of $341.61 million as of May 26, 2026. Its market cap has increased by 51.69% in one year.
Market Cap
341.61M
Enterprise Value
224.54M
1-Year Change
51.69%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $341.61M, an increase of 104.55%. That is a compound annual growth rate of 13.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 313.00M | 43.05% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 353.72M |
| Immuneering | 348.72M |
| Fennec Pharmaceuticals | 344.94M |
| Neumora Therapeutics | 337.97M |
| YD Bio | 334.02M |
| REGENXBIO | 328.28M |
| Palisade Bio | 326.48M |
| Lineage Cell Therapeutics | 324.09M |